Inventor · disambiguated record
Jijun Yuan
Also filed as: YUAN JIJUN
7 granted patents·5 pending applications·43 citations·filing 2011–2022
80Inventor score
Files withSHANGHAI GENBASE BIOTECHNOLOGY CO LTD6Shanghai hengrui pharmaceutical co ltd3CHINESE PEOPLE'S LIBERATION ARMY AIR FORCE MILITARY MEDICAL UNIV1SUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD1YANG FANGLONG1
Top patents by PatentIndex Score
12 records- 0192US10344090B2PD-1 antibody, antigen-binding fragment thereof, and medical application thereofShanghai hengrui pharmaceutical co ltd·Filed 2014·Granted Jul 9, 2019·15 cites·27 claims
- 0290US10206980B2IL-15 heterodimeric protein and uses thereofShanghai hengrui pharmaceutical co ltd·Filed 2014·Granted Feb 19, 2019·20 cites·19 claims
- 0386US11365255B2PD-1 antibody, antigen-binding fragment thereof, and medical application thereofSUZHOU SUNCADIA BIOPHARMACEUTICALS CO LTD·Filed 2019·Granted Jun 21, 2022·2 cites·12 claims
- 0474US8609622B2C-aryl glucoside derivatives, preparation process and pharmaceutical use thereofYANG FANGLONG·Filed 2011·Granted Dec 17, 2013·6 cites·26 claims
- 0546US12037409B2Antibody specifically bound to glycosylated CEACAM5SHANGHAI GENBASE BIOTECHNOLOGY CO LTD·Filed 2021·Granted Jul 16, 2024·0 cites·5 claims
- 0646US2024123070A1Epitope peptide of ras g13d mutant and t cell receptor recognizing ras g13d mutantSHANGHAI GENBASE BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
- 0745US2024000834A1Ras mutant epitope peptide and t cell receptor recognizing ras mutantSHANGHAI GENBASE BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
- 0843US2024150455A1Anti-cldn6 antibody and use thereofSHANGHAI GENBASE BIOTECHNOLOGY CO LTD·Filed 2021·Application pending·0 cites
- 0940US9458219B2Human insulin analogue and acylated derivative thereofShanghai hengrui pharmaceutical co ltd·Filed 2012·Granted Oct 4, 2016·0 cites·23 claims
- 1038US2021403552A1Anti-cldn18.2 antibody and uses thereofSHANGHAI GENBASE BIOTECHNOLOGY CO LTD·Filed 2018·Application pending·0 cites
- 1136US2022331363A1Bcma-targeted antibody and chimeric antigen receptorSHANGHAI GENBASE BIOTECHNOLOGY CO LTD·Filed 2019·Application pending·0 cites
- 1230US11266688B2Single-chain antibody specifically binding MG7, highly glycosylated CEA and use thereof in detection and therapyCHINESE PEOPLE'S LIBERATION ARMY AIR FORCE MILITARY MEDICAL UNIV·Filed 2017·Granted Mar 8, 2022·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Jijun Yuan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →